Propolis effects on ovarian cancer

Using propolis on patients with epithelial ovarian cancer receiving adjuvant chemotherapy,reducing side effects

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200914048723N1

Enrollment

Registered

2022-10-17

Start date

2020-09-22

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epithelial ovarian cancer.

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women with epithelial ovarian cancer whom underwent optimal surgery Individuals candidated for post-surgery chemotherapy

Exclusion criteria

Exclusion criteria: Past medical history including renal,liver or hematological diseases Past medical history of chemotherapy or radiotherapy

Design outcomes

Primary

Measure	Time frame
Incidence and severity of gastrointestinal side effects including nausea and vomiting. Timepoint: at the beginning and the end of the treatment. Method of measurement: using VAS, liver function test, white blood cell count, creatinine, and the amount of ca125 tumor marker.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElnaz Sadat Hosseini

Mashhad University of Medical Sciences

Hoseinies971@mums.ac.ir+98 51 3846 2390

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026